Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
25.32
+0.37 (1.48%)
Nov 13, 2026, 4:00 PM EST - Market closed

Collegium Pharmaceutical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
38.1762.8769.1948.16-2571.52
Depreciation & Amortization
232.93226.07169.16149.26134.1568.92
Other Amortization
4.375.346.028.648.293.41
Asset Writedown & Restructuring Costs
----4.79-
Loss (Gain) From Sale of Investments
-0.48-1.07-2.03-1.24--
Stock-Based Compensation
47.5641.9132.427.1422.8724.26
Other Operating Activities
-33.65-9.56-14.7821.07-8.15-78.02
Change in Accounts Receivable
-18.2517.2-4.413.59-21.78-22.52
Change in Inventory
11.19-5.3513.9314.1748.27-2.3
Change in Accounts Payable
0.366.72-11.285.06-0.71-5.83
Change in Unearned Revenue
0.45-0.22----
Change in Other Net Operating Assets
55.37-14.59-53.21-1.09-38.544.13
Operating Cash Flow
338.02329.32204.98274.75124.23103.56
Operating Cash Flow Growth
16.19%60.66%-25.39%121.16%19.96%10.23%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.73-1.74-1.65-0.46-1.62-1.94
Cash Acquisitions
-655.4--267.54--572.07-
Investment in Securities
135.83-61.79-18.57-70.35--
Investing Cash Flow
-521.31-63.53-287.76-70.81-573.69-1.94

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-565.18325241.5517.68-
Long-Term Debt Repaid
--635.56-305.66-301.14-75-50
Net Debt Issued (Repaid)
251.8-70.3819.34-59.64442.68-50
Issuance of Common Stock
4.135.6411.079.112.1512.71
Repurchase of Common Stock
-67.94-37.95-79.2-83.36-18.11-52.01
Other Financing Activities
-9.99-7.56-11.83-6.28--
Financing Cash Flow
178-110.25-60.6-140.18436.72-89.3

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-5.29155.55-143.3863.76-12.7412.31

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
336.29327.58203.33274.29122.61101.61
Free Cash Flow Growth
16.24%61.11%-25.87%123.71%20.66%14.95%
Free Cash Flow Margin
41.25%41.97%32.20%48.39%26.43%36.70%
Free Cash Flow Per Share
9.618.255.036.563.622.48
Levered Free Cash Flow
366.99321.54362.08264.8770.53109.21
Unlevered Free Cash Flow
410.51367.65402.3308.32101.75118.93

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
72.4768.7662.4373.2652.5317.61
Cash Income Tax Paid
50.1660.0452.0924.2110.43.01
Change in Working Capital
49.123.76-54.9821.73-12.7113.49
SEC Filings: 10-K · 10-Q